Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 2:22 pm Purchase |
2025-03-31 | 13G | Cytosorbents Corporation CTSO |
Skylands Capital, LLC | 3,002,702 4.800% |
221,080 (+7.95%) |
Filing History |
| 2025-02-14 10:22 am Purchase |
2024-12-31 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 3,093,946 5.700% |
42,544 (+1.39%) |
Filing History |
| 2025-01-31 6:49 pm Purchase |
2024-12-31 | 13G | Cytosorbents Corporation CTSO |
The Vanguard Group | 3,899,102 7.130% |
1,942,274 (+99.26%) |
Filing History |
| 2025-01-17 4:05 pm Purchase |
2025-01-13 | 13G | Cytosorbents Corporation CTSO |
SATTERFIELD THOMAS A JR | 3,998,867 6.560% |
3,998,867 (New Position) |
Filing History |
| 2025-01-07 1:26 pm Sale |
2024-12-31 | 13G | Cytosorbents Corporation CTSO |
Skylands Capital, LLC | 2,781,622 5.100% |
-472,591 (-14.52%) |
Filing History |
| 2024-11-14 4:48 pm Sale |
2024-09-30 | 13G | Cytosorbents Corporation CTSO |
Granahan Investment Management LLC | 2,094,882 3.850% |
-1,523,261 (-42.10%) |
Filing History |
| 2024-02-14 4:42 pm Purchase |
2023-12-31 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 3,051,402 6.870% |
604,313 (+24.70%) |
Filing History |
| 2024-02-14 09:00 am Purchase |
2023-12-31 | 13G | Cytosorbents Corporation CTSO |
Granahan Investment Management LLC | 3,618,143 6.930% |
3,618,143 (New Position) |
Filing History |
| 2024-01-08 3:00 pm Purchase |
2023-12-31 | 13G | Cytosorbents Corporation CTSO |
Skylands Capital, LLC | 3,254,213 7.300% |
712,122 (+28.01%) |
Filing History |
| 2023-02-14 1:08 pm Purchase |
2022-12-31 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,447,089 5.610% |
259,307 (+11.85%) |
Filing History |
| 2023-02-09 11:16 am Sale |
2022-12-30 | 13G | Cytosorbents Corporation CTSO |
The Vanguard Group | 1,956,828 4.480% |
-252,337 (-11.42%) |
Filing History |
| 2023-02-07 2:28 pm Purchase |
2022-12-31 | 13G | Cytosorbents Corporation CTSO |
Skylands Capital, LLC | 2,542,091 5.800% |
2,542,091 (New Position) |
Filing History |
| 2022-08-11 08:39 am Purchase |
2022-07-26 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,187,782 5.020% |
30,949 (+1.43%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Cytosorbents Corporation CTSO |
BLACKROCK INC BLK |
744,958 1.700% |
-1,886,252 (-71.69%) |
Filing History |
| 2022-06-27 5:34 pm Sale |
2022-05-26 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,156,833 4.950% |
-20,313 (-0.93%) |
Filing History |
| 2022-04-22 5:34 pm Purchase |
2022-03-22 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,177,146 5.000% |
89,075 (+4.27%) |
Filing History |
| 2022-02-09 3:43 pm Sale |
2021-12-31 | 13G | Cytosorbents Corporation CTSO |
The Vanguard Group | 2,209,165 5.080% |
-12,441 (-0.56%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Cytosorbents Corporation CTSO |
BLACKROCK INC BLK |
2,631,210 6.100% |
-131,078 (-4.75%) |
Filing History |
| 2022-01-07 5:10 pm Sale |
2021-12-20 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,088,071 4.800% |
-156,264 (-6.96%) |
Filing History |
| 2021-12-13 5:01 pm Purchase |
2021-11-16 | 13G | Cytosorbents Corporation CTSO |
AVENIR CORP | 2,244,335 5.160% |
2,244,335 (New Position) |
Filing History |